- Euro Zone Jumps Out of Recession in Third Quarter
- Saudi Arabia to Double Total Refining Capacity by 2015
- GM Still Wants State Aid for Opel Restructuring
- IMF Chief Does Not See Double-Dip US Recession
- Joint Effort Needed to Unwind Stimulus: APEC Leaders
- Obama to Outline Strategy to Boost US Exports to Asia
- Friday May See 'Risk Trade' Stalling; Dollar in Focus
- Former Bankers Look to Buy Failing Banks: Report
- Job Market Politics to Keep Interest Rates Low
- EXCERPTS and IMAGES: Warren Buffett & Bill Gates - Keeping America Great
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Gold Is a Bad Inflation Hedge—Like Oil: Stock Picker
- Intel's Andy Bryant Offers An Explanation
- US 'Actively Working' on Weaker Dollar: Fund Manager
- Options Boil on Biotech Buyout Rumors
- Warren Buffett's $100,000 Offer and $500,000 Advice for Columbia Business School Students
- Activision Blizzard's "Modern Warfare 2" Sales Break Records
- 5-Star Manager's 5 Stocks for Changing Markets
- Finnish inflation rate lowest in half a century
- Iberia reports euro16.4 million Q3 loss
- French economy expands 0.3 pct in Q3
- Airbus military transporter cleared for testing
- Chesapeake crabbers not going for Va.'s buyout
- Chinese president pledges to boost domestic demand
- US commerce secretary: Trade pacts must wait
- UK's Balfour Beatty acquires SpawMaxwell of Texas
- China rejects $28B in steel, chemical projects
Text Size 
SILVER SPRING, Md. - The U.S. Food and Drug Administration sent a warning letter Friday to Procter & Gamble Co. saying the company was illegally marketing two Vicks cold and flu medicines containing vitamin C.
The FDA said the single-dose combinations of drug and dietary ingredients in Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C cannot be marketed legally because they have not been proven safe and effective.
The agency also said it had previously determined that there was insufficient data to show vitamin C is safe and effective in preventing or treating the common cold.
Earlier this month the agency issued a similar warning letter but then quickly retracted it. FDA spokesman Christopher Kelly said Friday the letter was "issued prematurely — it had not completed our internal clearance process."
The FDA said it allows some over-the-counter drugs to be marketed without agency approval, but that the two Vicks products did not comply with its rules and first must be evaluated and approved under the FDA's new drug approval process.
A spokeswoman for the Cincinnati consumer products company noted in an e-mail message that the FDA warning was "not new news," referring to the earlier warning letter.
"It's also not about the safety or quality of the Vicks NyQuil or DayQuil brands," wrote Kate DiCarlo. "We believe we are marketing within FDA guidelines and regulations, and we'll continue to work closely with the FDA to resolve any concerns."
Shares of P&G, the world's largest consumer products maker, slid $1.46, or 2.5 percent, to $58.08 in afternoon trading.
Print
Email
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- They may have wrecked their companies or saved our economy. Tell us what you think.
- Big pharma embraces social media, but how much should a tightly regulated sector say on Facebook or Twitter?
- A European dating site finds lovelorn singles from one country to be consistently uglier. Which is it?
- Contributor David Pogue looks at two of the latest efforts to perfect the digital pocket camera.
- PepsiCo is ramping up its onsite health facilities for workers.
Data is a real-time snapshot *Data is delayed at least 15 minutes